1. What type of work are you involved in the cancer therapy research?

    The cancer research program at JRC-ITU focuses on all stages of developing targeted alpha therapy (TAT) from bench to bedside, including the development of innovative methods for the production of alpha emitters, pre-clinical studies in vitro and in vivo, as well as conducting clinical trials in collaboration with hospitals in Europe and world-wide.

    Institutes: ITU
    Keywords: nuclear, actinide, cancer, citizen, collaboration, health, innovation, microbiology